Page last updated: 2024-11-04

rofecoxib and Spondylarthropathies

rofecoxib has been researched along with Spondylarthropathies in 1 studies

Spondylarthropathies: Heterogeneous group of arthritic diseases sharing clinical and radiologic features. They are associated with the HLA-B27 ANTIGEN and some with a triggering infection. Most involve the axial joints in the SPINE, particularly the SACROILIAC JOINT, but can also involve asymmetric peripheral joints. Subsets include ANKYLOSING SPONDYLITIS; REACTIVE ARTHRITIS; PSORIATIC ARTHRITIS; and others.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vinsonneau, U1
Brondex, A1
Mansourati, J1
Saraux, A1
Cornily, JC1
Arlès, F1
Godon, P1
Quiniou, G1

Reviews

1 review available for rofecoxib and Spondylarthropathies

ArticleYear
Cardiovascular disease in patients with spondyloarthropathies.
    Joint bone spine, 2008, Volume: 75, Issue:1

    Topics: Antirheumatic Agents; Atherosclerosis; Atrioventricular Block; Cardiovascular Diseases; Comorbidity;

2008